Nanoformulations in Glucocorticoid Therapy: a Promising Leap for Atopic Dermatitis Treatment
A chronic inflammatory skin disorder characterized by pruritus, recurrent flares and significant impairment of quality of life is termed as atopic dermatitis (AD). Although glucocorticoids (GCs) remain the cornerstone of therapy, their long-term use is limited by adverse effects including cutaneous atrophy, immunosuppr...